- 01Perimenopause is identified from age and symptoms, not from a hormone number
During perimenopause FSH and estradiol rise and fall from one week to the next, sometimes landing in the postmenopausal range and sometimes back in the range of a 30-year-old. A single normal FSH therefore cannot rule perimenopause out, and a single high one cannot date it. That is why NICE says to identify it in otherwise healthy people aged 45 or over from new hot flashes or night sweats plus a change in the menstrual cycle, without laboratory tests.
- 02The useful blood tests rule out look-alikes
Thyroid disease, iron deficiency from heavy periods, pregnancy and a raised prolactin can all cause irregular periods, tiredness, sweats or low mood. A TSH, a blood count with ferritin, a pregnancy test and sometimes prolactin answer those questions cleanly, which is where blood tests earn their place in the perimenopause years.
Perimenopause is the stretch of years before menopause when the ovaries wind down unevenly. Periods start to change, and hot flashes, night sweats, broken sleep and mood changes often begin. It usually starts in the mid-40s and ends 12 months after the final period. 34 The short answer to the most searched question is that no single blood test can detect perimenopause, because FSH (follicle-stimulating hormone, the brain's signal to the ovaries) and estradiol (the main estrogen) swing too much from week to week. 2 In otherwise healthy people aged 45 or over, NICE (the UK's National Institute for Health and Care Excellence) says to identify it from symptoms and cycle changes alone. 1 What to do next: keep a simple record of your periods and symptoms for two or three months and bring it to your clinician, and ask which tests would rule out thyroid disease, iron loss and pregnancy.
Symptoms of perimenopause
Symptoms run from barely noticeable to disruptive, and they can come and go for years. None of them is unique to perimenopause, so the lists below are things to mention to your clinician, not a way to diagnose yourself. 13
- Periods closer together, further apart, heavier, lighter or skipped
- Hot flashes: sudden heat in the face, neck and chest, sometimes with flushing and sweating
- Night sweats that wake you
- Trouble falling or staying asleep
- Irritability, low mood or anxiety
- Forgetfulness or trouble concentrating (often called brain fog)
- Joint and muscle aches
- Vaginal dryness or pain during sex
- Lower sex drive
- Needing to pee more often, or more urinary infections
- Tiredness from heavy periods and falling iron
- Heart pounding with hot flashes
Get care the same day Seek same-day care for very heavy bleeding with dizziness, fainting, shortness of breath or a racing heart, because blood loss can cause severe anemia. Bleeding or spotting after 12 months without a period, bleeding between periods or after sex, or periods lasting more than a week need a prompt appointment, because they have causes other than perimenopause that should be checked. 3
Symptom lists drawn from NICE NG23 and the US National Institute on Aging 13. Associations only, never a way to diagnose yourself.
What is perimenopause?
Perimenopause means "around menopause". It covers the menopausal transition, when periods become irregular, plus the first 12 months after the final menstrual period (FMP). Menopause itself is a single point in time, recognised only in hindsight once 12 months have passed with no period. 2 MedlinePlus says perimenopause usually starts around age 45, and the US National Institute on Aging says most women begin the transition between 45 and 55, with the final period at an average age of 52 in the United States. 43
The driver is the ovary's shrinking supply of egg-containing follicles. Fewer follicles make less inhibin B and anti-Müllerian hormone (AMH), the hormones that normally keep FSH in check, so the pituitary gland in the brain pushes out more FSH to get a follicle to grow. Some months that extra push overshoots and estradiol runs higher than usual; other months no egg is released, progesterone stays low and the period is late or skipped. 2 That stop-start pattern explains the symptoms and the confusing blood tests.
How perimenopause unfolds, step by step
Perimenopause age and stages
Researchers stage reproductive aging with STRAW+10 (the Stages of Reproductive Aging Workshop, updated in 2011), which places a woman by her bleeding pattern first and her hormones second. 2 In plain words:
| Stage | What happens to periods | What happens to hormones | Typical length |
|---|---|---|---|
| Late reproductive | Regular, perhaps slightly shorter cycles | AMH and antral follicle count low; FSH starts to vary 2 | Years |
| Early menopausal transition | A persistent difference of 7 days or more between consecutive cycles 2 | FSH raised but variable; AMH low 2 | Variable |
| Late menopausal transition | A gap of 60 days or more without a period 2 | Random FSH above 25 IU/L is typical; hot flashes most likely 2 | 1 to 3 years on average 2 |
| Early postmenopause (first year) | None for 12 months: menopause is dated to the final period | FSH still rising, estradiol still falling 2 | Perimenopause ends here 2 |
| Later postmenopause | None | FSH high and steady, estradiol low from about 2 years after the final period 2 | Rest of life |
How long perimenopause lasts depends a lot on when it starts. In the Study of Women's Health Across the Nation (SWAN), the median length of the menopausal transition ran from about 4.4 years in women who started it latest to about 8.6 years in those who started it earliest. 9 SWAN also found that African American women reported the longest total duration of hot flashes, a median of 10.1 years. 8 NICE adds that people from some ethnic minority backgrounds and people with some lifelong conditions may reach menopause younger. 1
Early perimenopause: under 45 and under 40
Menopause between 40 and 44 is called early menopause, and loss of normal ovarian function before 40 is premature ovarian insufficiency (POI). The 2024 ESHRE (European Society of Human Reproduction and Embryology) guideline puts POI at about 3.5% of women in recent studies, higher than once thought, and diagnoses it from disordered periods for at least 4 months plus an FSH above 25 IU/L. 10 Blood tests matter here in a way they do not at 47: NICE recommends considering FSH between 40 and 45, and testing it under 40. 1 POI raises long-term risks to bone and heart, so it needs a specialist rather than a wait-and-see approach. 10
Can a blood test detect perimenopause?
Not reliably, and guidelines say so plainly. NICE recommends identifying perimenopause "without laboratory tests" in otherwise healthy women, trans men and non-binary people registered female at birth who are aged 45 or over, if they have vasomotor symptoms (hot flashes and night sweats) that have recently started and any change in their menstrual cycle. 1 It goes further and lists tests not to use for this at 45 or over: anti-Müllerian hormone, inhibin A, inhibin B, estradiol, antral follicle count and ovarian volume. 1 MedlinePlus agrees that at 45 or older, FSH testing usually is not needed, because a high FSH is an expected sign of the transition. 4 The reason is the hormone swing that STRAW+10 describes:
In this stage, FSH levels are sometimes elevated into the menopausal range and sometimes within the range characteristic of the earlier reproductive years, particularly in association with high estradiol levels.
When FSH testing is used
| Situation | How it is identified | Role of an FSH blood test |
|---|---|---|
| Aged 45 or over, otherwise healthy, with new hot flashes and cycle changes | Symptoms and cycle pattern 1 | Not needed; NICE advises against AMH, estradiol and inhibin here 1 |
| Aged 40 to 45 with symptoms and cycle changes | Symptoms plus a blood test 1 | Consider FSH to support the picture 1 |
| Under 40 with missed or irregular periods | POI criteria 10 | FSH above 25 IU/L; NICE asks for 2 samples 4 to 6 weeks apart, ESHRE 2024 accepts one unless in doubt 110 |
| On combined hormonal contraception or high-dose progestogen | Clinical judgement | FSH not used: these medicines suppress it 1 |
| After a hysterectomy with ovaries kept | Type and pattern of symptoms 1 | Sometimes used when symptoms are unclear |
Where an example FSH of 5.4 falls for a 47-year-old with irregular periodsmIU/mL
FSH 5.4, 10, 25 or 40: what an FSH number means in perimenopause
FSH is reported in mIU/mL or IU/L, which give the same number. These readings use Labcorp's adult female ranges; your own lab's range and the day of your cycle come first. 5
- FSH of 5.4 mIU/mL: inside the follicular range (3.5 to 12.5). Normal on paper, and it does not rule perimenopause out if symptoms and cycle changes fit. 52
- FSH of 10 mIU/mL: still inside the follicular range. In the early transition, early-cycle FSH is often higher than it was at 30 but not flagged. 52
- FSH of 15 to 25 mIU/mL: above the follicular range but below the postmenopausal one. In the 40s this is a common in-between reading; mid-cycle, FSH can reach 21.5 in a normal cycle. 5
- FSH above 25 mIU/mL: in a random draw, typical of the late menopausal transition; under 40, the POI threshold. 210
- FSH of 40 or more: inside Labcorp's postmenopausal range (25.8 to 134.8), but in perimenopause it can fall back the next month, so it does not date the final period or mean pregnancy is impossible. 52
Blood tests to check: what each one rules in or out
When a clinician orders blood work for perimenopause-type symptoms, most of it is aimed at the conditions that copy perimenopause, rather than at perimenopause itself. Each marker below links to its own page with full ranges. See how reference ranges work for why the band printed on your report is the one that applies.
| Marker | What it shows here | Typical cutoff or reading | First-line or add-on |
|---|---|---|---|
| hCG (pregnancy test) | Pregnancy as the cause of a missed or late period | Positive means pregnant | First-line when a period is missed |
| TSH (thyroid-stimulating hormone) | An underactive or overactive thyroid, which can mimic sweats, tiredness, mood change and cycle change | Outside the lab's range prompts a free T4 | First-line |
| Hemoglobin | Anemia from heavy or frequent periods | Below the lab's range for women | First-line with heavy bleeding |
| Ferritin | Iron stores, which fall before hemoglobin does | Low ferritin means depleted stores | First-line with heavy bleeding or tiredness |
| FSH | The pituitary's push on the ovaries | Follicular 3.5 to 12.5; postmenopausal 25.8 to 134.8 mIU/mL 5 | Add-on, mainly under 45 1 |
| Estradiol (E2) | The main estrogen, which swings high and low | No value diagnoses perimenopause 1 | Add-on; not advised for diagnosis at 45 or over 1 |
| Prolactin | A pituitary hormone that can stop periods when high | Above the lab's range needs a repeat and review | Add-on when periods stop or nipple discharge appears |
| AMH | The remaining egg supply | Low or undetectable as menopause nears 2 | Not advised for diagnosis at 45 or over 1 |
| LH | The partner pituitary hormone to FSH | Rises with FSH in the transition; read beside FSH | Add-on for PCOS or pituitary questions |
| Progesterone | Whether that cycle released an egg | A luteal-phase rise shows ovulation | Add-on, rarely needed |
| Vitamin D (25-OH) | Vitamin D status, relevant to bone | See the marker page | Add-on when bone risk is high |
| LDL cholesterol (the main artery-clogging cholesterol) | Heart risk, which starts to rise around the final period | See the marker page | Routine adult screening |
How the results read together
| Pattern | What it usually means |
|---|---|
| Age 45 or over, new night sweats, irregular cycles, normal TSH and blood count | Perimenopause is the likely explanation; hormone tests add little 1 |
| Normal FSH, but symptoms and cycle changes fit | Still consistent with perimenopause, because FSH swings 2 |
| High FSH with low estradiol in two draws weeks apart, under 40 | Fits premature ovarian insufficiency; specialist referral 110 |
| Low ferritin and low hemoglobin with heavy periods | Iron-deficiency anemia from blood loss; the bleeding itself needs assessment |
| High TSH with low free T4 | An underactive thyroid, which can explain tiredness, weight gain and heavier periods |
| Low TSH with high free T4 | An overactive thyroid, which can explain sweats, palpitations and lighter or fewer periods |
| High prolactin with missed periods | A pituitary cause or a medicine effect, read with a repeat sample |
| Positive hCG | Pregnancy, at any age before menopause is confirmed |
Conditions that mimic perimenopause
Most of the common perimenopause symptoms have other causes that a blood test can settle. These are the ones clinicians think of first, with the test that tells them apart.
| Look-alike | Symptoms it shares | The test that tells them apart |
|---|---|---|
| Hypothyroidism (underactive thyroid) | Tiredness, low mood, weight gain, heavier periods, brain fog | TSH with free T4 (the thyroid hormone itself) |
| Hyperthyroidism (overactive thyroid) | Sweating, heat intolerance, palpitations, poor sleep, lighter periods | TSH with free T4 |
| Iron deficiency and anemia | Tiredness, breathlessness, poor concentration, palpitations | Ferritin and hemoglobin |
| Pregnancy | Missed period, tiredness, mood change | hCG |
| PCOS (polycystic ovary syndrome) | Irregular periods, weight change, acne or extra hair | Total testosterone, and a history of irregular cycles since the teens |
| High prolactin | Missed periods, low sex drive, nipple discharge | Prolactin |
| Depression or anxiety | Low mood, poor sleep, irritability | A clinical assessment; perimenopause and depression can overlap |
Two of these deserve a closer look. Thyroid disease is common in midlife women and shares almost every perimenopause symptom, so a TSH is one of the most useful first blood tests for this group of symptoms; the hypothyroidism guide covers the numbers. Heavy periods in the transition can drain iron for months before hemoglobin falls, so a normal hemoglobin with a low ferritin is a common finding; the iron deficiency guide covers what the ferritin cutoffs mean.
Perimenopause vs menopause: what is the difference?
Perimenopause is the transition; menopause is the date it ends
After the final period the blood tests that matter change: LDL cholesterol, blood sugar and bone become the focus. The menopause guide covers what to check after the last period and the FSH numbers people search for then.
Perimenopause treatment: what can help, and how strong the evidence is
Treatment targets symptoms, not a hormone number, and the choice depends on which symptoms bother you most, your age, your periods and your personal risks. The table grades the main options by the evidence behind them. Prescription options are listed as facts; whether any of them fits is a decision for you and your clinician.
| Approach | What the evidence shows | Strength | Cautions |
|---|---|---|---|
| Hormone therapy (estrogen, with a progestogen if you have a uterus) | The most effective treatment for hot flashes, night sweats and vaginal symptoms; favorable benefit-risk under 60 or within 10 years of menopause 6 | Strong | Not for everyone with a history of breast cancer, blood clots, stroke or liver disease; a clinician decision 6 |
| Menopause-specific cognitive behavioral therapy (CBT) | Recommended for hot flashes in both NICE and The Menopause Society reviews 17 | Strong | Needs a trained therapist or a structured program |
| Non-hormonal prescriptions (fezolinetant, SSRIs or SNRIs, gabapentin, oxybutynin) | Recommended by The Menopause Society for hot flashes (Level I, oxybutynin Levels I to II) 7 | Strong to moderate | Side effects vary; NICE keeps SSRIs, SNRIs and clonidine off the first line for hot flashes alone 1 |
| Clinical hypnosis | Recommended for hot flashes by The Menopause Society (Level I) 7 | Moderate | Access is limited |
| Weight loss, where weight is high | Recommended for hot flashes (Levels II to III) 7 | Limited | Helps heart and metabolic risk too |
| Black cohosh | A 2023 review of 22 studies found possible benefit for overall symptoms and hot flashes; The Menopause Society does not recommend herbal remedies 117 | Limited | Rare liver injury reported; products vary 11 |
| Soy foods, soy extracts, isoflavones | NICE notes some evidence; The Menopause Society does not recommend them for hot flashes (Level II) 17 | Limited | Preparations vary; interactions possible 1 |
| Magnesium for sleep | Three small trials in 151 older adults: fell asleep about 17 minutes faster; low to very low quality evidence, not tested in perimenopause 12 | Limited | Kidney disease raises magnesium levels; laxative effect |
| Omega-3 and vitamin D for hot flashes | Supplements and herbal remedies as a group are not recommended for hot flashes (Levels I to II) 7 | Not supported | Vitamin D matters for bone when intake is low; omega-3 has its own heart evidence |
| Cooling, avoiding triggers, exercise, yoga, paced breathing | Not recommended as treatments for hot flashes, though exercise has broad health benefits 7 | Not supported for hot flashes | Still worth it for sleep, mood, bone and heart |
Hormone therapy in perimenopause
Hormone therapy, also called hormone replacement therapy (HRT) or menopausal hormone therapy, replaces estrogen; anyone with a uterus also needs a progestogen (a progesterone-like hormone) to protect the womb lining. The Menopause Society's 2022 position statement calls it the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause (vaginal and urinary symptoms), and judges the benefit-risk balance favorable for women younger than 60 or within 10 years of menopause who have no contraindications. 6 NICE recommends offering it for hot flashes and night sweats. 1 In perimenopause, when periods still come, a clinician also weighs bleeding patterns and contraception, because standard HRT is not a contraceptive.
US labels are changing. On 10 November 2025 the FDA asked the makers of menopausal hormone therapy to remove the statements about heart disease, breast cancer and probable dementia from the boxed warning, the label's most prominent warning. 13 The heart disease and breast cancer warnings stay elsewhere in the label, the boxed warning about endometrial (womb lining) cancer stays on systemic estrogen-alone products, and labels for systemic products add that starting treatment for moderate to severe hot flashes can be considered before 60 or within 10 years of menopause. 13 Updated labels for the first products followed from February 2026. 13 A label change does not change any one person's risks; the type, dose, route and timing of hormone therapy still matter. 6
Non-hormonal options
For people who cannot or prefer not to use hormones, The Menopause Society's 2023 nonhormone statement recommends cognitive behavioral therapy, clinical hypnosis, SSRIs or SNRIs (antidepressant families that also calm hot flashes), gabapentin and fezolinetant, a non-hormonal pill that blocks a brain receptor involved in temperature control, all at its strongest evidence level. 7 NICE recommends fezolinetant when HRT is unsuitable. 1 Each has its own side effects and checks, which is why the choice sits with a clinician.
Supplements: what the trials show
Most supplements test poorly for hot flashes. The Menopause Society's 2023 review does not recommend supplements or herbal remedies for them, soy included. 7 Black cohosh has the most data: the US National Center for Complementary and Integrative Health (NCCIH) reports a 2023 review of 22 studies that found possible benefit for overall symptoms and hot flashes, alongside rare reports of liver damage and products that contained the wrong herb. 11 For sleep, magnesium has weak evidence from three small trials in older adults, none of them in perimenopause. 12 Vitamin D and calcium matter for bone, which can change around menopause 3; the osteoporosis guide covers who is screened and when. Omega-3 has its own heart evidence but no hot flash benefit.
If you and your clinician decide a supplement makes sense, LifeFrom's shop lists magnesium on its own and two ready-made packs: a Perimenopause pack (cordyceps, fenugreek, magnesium, DIM and DHEA) and a Women's wellness pack (omega-3, vitamin C, a probiotic, a multivitamin, ashwagandha and D Complex). None of the ingredients in either pack is among the options graded above, and The Menopause Society does not recommend supplements or herbal remedies for hot flashes. 7 The Perimenopause pack contains DHEA (a hormone the body turns into testosterone and estrogen) and DIM (a compound that changes how estrogen is processed), both hormone-active, so it needs a clinician's view first. It is not suitable during pregnancy or breastfeeding, under 18, alongside hormone therapy, hormonal contraception or hormone-blocking medicines such as tamoxifen, or with a hormone-sensitive condition such as some breast cancers, endometriosis or fibroids, and DHEA can cause acne and unwanted hair growth. People with kidney disease need a clinician's view before any magnesium.
Monitoring and retesting during perimenopause
Perimenopause itself is not monitored with hormone tests. What gets rechecked depends on what turned up and on the treatment chosen. A single reading says less than a series; see why a trend beats a single blood test.
| What | When it is usually rechecked | Why |
|---|---|---|
| Period and symptom diary | Ongoing; bring 2 to 3 months to appointments | The cycle pattern is the diagnosis 12 |
| Hemoglobin and ferritin | After iron treatment starts, and while periods stay heavy | Heavy bleeding can drain iron again |
| TSH | If symptoms change, or on thyroid treatment | Thyroid disease is common in midlife |
| FSH | Repeated 4 to 6 weeks later only when POI is in question under 40 110 | One FSH does not settle the diagnosis 1 |
| Hormone therapy review | At 3 months, then once a year unless problems arise sooner (NICE) 1 | Symptom control, bleeding and side effects |
| Blood pressure, LDL cholesterol and blood sugar | Per routine adult screening, with attention after the final period | Heart disease risk rises after menopause 3 |
| Bone density scan (DEXA) | Earlier than 65 when risk factors are present | Bone density can change around menopause 3 |
Questions to ask your clinician
- Do my symptoms and cycle changes fit perimenopause, or should we rule out thyroid disease, iron deficiency, pregnancy or a high prolactin first?
- Is an FSH test useful at my age, or would it add nothing?
- My periods are heavy: should my hemoglobin and ferritin be checked, and does the bleeding itself need an ultrasound?
- Am I a candidate for hormone therapy, and which type and route fit my history?
- If not hormones, which non-hormonal options fit my symptoms and other medicines?
- Do I still need contraception, and for how long?
- Should my blood pressure, cholesterol, blood sugar or bone density be checked now?
To go further, LifeFrom's menopause page gathers the tests and guides for this stage of life, and the sleep page covers the other causes of broken nights. For reading the numbers themselves, see how reference ranges work and why trends beat single readings. Heavy periods and tiredness lead to the anemia guide.
This page is general education, not medical advice or a diagnosis. The clinician who knows your history, medicines and full results reads them and makes decisions with you.
Educational only: LifeFrom explains lab results and does not diagnose or treat. Bleeding after 12 months without a period, bleeding between periods or after sex, or very heavy bleeding with dizziness, a racing heart or fainting needs prompt or same-day care. Find the cause of symptoms with a clinician before starting anything, including supplements that act on hormones.
Citations
- NICE. Menopause: identification and management (NG23), recommendations 1.2 to 1.7. National Institute for Health and Care Excellence, updated 2024.
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-395.
- National Institute on Aging. What is menopause? US National Institutes of Health.
- MedlinePlus Lab Tests. Follicle-stimulating hormone (FSH) levels test. US National Library of Medicine.
- Labcorp. Test 004309: Follicle-stimulating hormone (FSH). Reference intervals for adult females.
- The 2022 hormone therapy position statement of The North American Menopause Society (now The Menopause Society). Menopause. 2022;29(7):767-794.
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition (SWAN). JAMA Intern Med. 2015;175(4):531-539.
- Paramsothy P, Harlow SD, Nan B, et al. Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women's Health Across the Nation. Menopause. 2017;24(2):142-149.
- ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024;2024(4):hoae065.
- National Center for Complementary and Integrative Health. Black cohosh: usefulness and safety. US National Institutes of Health.
- Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a systematic review and meta-analysis. BMC Complement Med Ther. 2021;21:125.
- US Food and Drug Administration. FDA requests labeling changes related to safety information to clarify the benefit/risk considerations for menopausal hormone therapies. Drug alert, 10 November 2025, updated 12 February 2026.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.






